Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Education
Published in: Journal of Cancer Education 1/2011

01-03-2011 | Reflections

The Mind Is for Seeing, the Heart Is for Hearing (Saudi Arabian Proverb)

Author: Ritu Lakhtakia

Published in: Journal of Cancer Education | Issue 1/2011

Login to get access

Abstract

These “reflections” offer a glimpse into Cancer sociology, through the eyes of a pathologist intimately involved in interdisciplinary management, at an Oncology centre. The interaction of a specialist, usually relatively remote from direct patient contact with cancer patients, evolved from diagnostician to confidante and co-traveler along a difficult journey. The range of shared experiences, the mutual human and humane accruals of this camaraderie are traced through a quarter century of living within the world of cancer and with those afflicted by it.
Metadata
Title
The Mind Is for Seeing, the Heart Is for Hearing (Saudi Arabian Proverb)
Author
Ritu Lakhtakia
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0136-4

Other articles of this Issue 1/2011

Journal of Cancer Education 1/2011 Go to the issue

Erratum

Erratum: Euro-Arab School of Oncology: an Educational Collaborative Activity of the European School of Oncology with the Arab World

Editorial

Do Recently Diagnosed Black Breast Cancer Patients Find Questions About Cancer Fatalism Acceptable? A Preliminary Report

OriginalPaper

Cancer Knowledge Increases After a Brief Intervention Among Arab Americans in Michigan

ReviewPaper

Recommendations for Enhancing Clinical Trials Education: a Review of the Literature

OriginalPaper

Understanding the Processes of Patient Navigation to Reduce Disparities in Cancer Care: Perspectives of Trained Navigators from the Field

OriginalPaper

The Art and Science of Cancer Education and Evaluation: Toward Facilitating Improved Patient Outcomes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits